Varian's Health Care unit booms in Q4

Article

A strong performance by the Health Care Systems business of Varian Associates helped buoy the Palo Alto, CA, company's financial results for the fourth quarter (end-September). Varian reported that its Health Care business turned in a fourth-quarter

A strong performance by the Health Care Systems business of Varian Associates helped buoy the Palo Alto, CA, company's financial results for the fourth quarter (end-September). Varian reported that its Health Care business turned in a fourth-quarter surge of sales that helped offset weakness experienced earlier this year.

Varian chairman and chief executive Tracy O'Rourke said that the Health Care business turned in the sharpest improvement among Varian's three main businesses, which include instruments and semiconductor equipment. Fourth-quarter sales for the unit were $158 million, rising 40% over the third quarter of 1997. O'Rourke attributed the improvement to acceptance of new cancer-care products from its oncology systems operation, as well as international sales.

For the entire company in the fourth quarter, Varian registered revenues of $405.8 million, down 2% compared with $413.4 million in the fourth quarter of fiscal 1996. The company's net income was $33 million, including a one-time gain from the sale of a business unit, compared with net income of $29.1 million in the fourth quarter of 1996.

For the year, Varian's revenues were $1.426 billion, down 11% compared with revenues of $1.599 billion in fiscal 1996. The company's net income was $115.6 million, compared with $122.1 million the prior year. Despite the lower revenues and net income, Varian said that all three of its businesses bounced back in the fourth quarter and should turn in strong performances in 1998.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.